DK2019872T3 - Fremgangsmåde til forudsigelse af modtageligheden over for TNF-blokkere - Google Patents

Fremgangsmåde til forudsigelse af modtageligheden over for TNF-blokkere

Info

Publication number
DK2019872T3
DK2019872T3 DK07789647.0T DK07789647T DK2019872T3 DK 2019872 T3 DK2019872 T3 DK 2019872T3 DK 07789647 T DK07789647 T DK 07789647T DK 2019872 T3 DK2019872 T3 DK 2019872T3
Authority
DK
Denmark
Prior art keywords
predicting susceptibility
tnf blockers
genes
patient
tnf
Prior art date
Application number
DK07789647.0T
Other languages
English (en)
Inventor
Loa T Xavier Le
Maryvonne Daveau
Anne-Christine Gauthier-Jauneau
Olivier Vittecoq
Alain Daragon
Othmane Mejjad
Thierry Lequerre
Jean-Philippe Salier
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of DK2019872T3 publication Critical patent/DK2019872T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Materials Using Thermal Means (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK07789647.0T 2006-05-16 2007-05-15 Fremgangsmåde til forudsigelse af modtageligheden over for TNF-blokkere DK2019872T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06290789A EP1857559A1 (en) 2006-05-16 2006-05-16 A method for predicting responsiveness to TNF alpha blocking agents
PCT/IB2007/002373 WO2007135568A2 (en) 2006-05-16 2007-05-15 A METHOD FOR PREDICTING RESPONSIVENESS TO TNFα BLOCKING AGENTS

Publications (1)

Publication Number Publication Date
DK2019872T3 true DK2019872T3 (da) 2012-01-16

Family

ID=36764554

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07789647.0T DK2019872T3 (da) 2006-05-16 2007-05-15 Fremgangsmåde til forudsigelse af modtageligheden over for TNF-blokkere

Country Status (7)

Country Link
US (1) US7985549B2 (da)
EP (2) EP1857559A1 (da)
AT (1) ATE530670T1 (da)
CA (1) CA2652087A1 (da)
DK (1) DK2019872T3 (da)
ES (1) ES2375865T3 (da)
WO (1) WO2007135568A2 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ581742A (en) * 2007-06-08 2012-09-28 Biogen Idec Inc Biomarkers for predicting anti-tnf responsiveness or non-responsiveness
US20110059445A1 (en) * 2008-03-28 2011-03-10 Paul Rutgeerts Mucosal gene signatures
WO2009150216A1 (en) * 2008-06-12 2009-12-17 INSERM (Institut National de la Santé et de la Recherche Médicale) A method for predicting the response to a treatment with anakinra
ES2335381B1 (es) * 2008-09-24 2011-02-28 Fundacio Institut De Recerca De L'hospital Universitari Vall D'hebron Metodo in vitro y kit para el pronostico o prediccion de la respuestapor parte de pacientes con artritis reumatoide al tratamiento con agentes bloqueantes del factor tnfalfa.
EP2192197A1 (en) * 2008-11-27 2010-06-02 Vereniging voor christelijk hoger onderwijs, wetenschappelijk onderzoek en patiëntenzorg Predicting clinical response to treatment with a soluble tnf-antagonist or tnf, or a tnf receptor agonist
KR20120104517A (ko) 2009-09-03 2012-09-21 제넨테크, 인크. 류마티스 관절염의 치료, 진단 및 모니터링 방법
RS61082B1 (sr) 2010-02-26 2020-12-31 Novo Nordisk As Stabilno antitelo koje sadrži kompozicije
JP2013526845A (ja) * 2010-03-24 2013-06-27 ティーシー・ランド・エクスプレッション サイトカイン標的薬(CyTD)に対する、炎症性疾患に罹患している対象の初期応答または非応答を予測する遺伝子および遺伝子の組み合わせ
RU2012153786A (ru) 2010-05-28 2014-07-10 Ново Нордиск А/С Стабильные многодозовые композиции, содержащие антитело и консервант
EP2680884B1 (en) 2011-02-28 2018-01-17 F. Hoffmann-La Roche AG Biological markers and methods for predicting response to b-cell antagonists
CN103782172A (zh) * 2011-07-06 2014-05-07 雀巢产品技术援助有限公司 检测针对使用TNFα的生物疗法的中和性自体抗体的测定法
CN104204230A (zh) 2012-02-10 2014-12-10 诺和诺德A/S(股份有限公司) 治疗炎性疾病和病症的相关方法
HU230680B1 (hu) * 2012-10-19 2017-08-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Diagnosztikai eljárás
WO2014134570A1 (en) * 2013-02-28 2014-09-04 Nodality, Inc. Compositions and methods for autoimmune disease
US20220364171A1 (en) * 2018-11-23 2022-11-17 Katholieke Universiteit Leuven Predicting a treatment response in inflammatory bowel disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US196799A (en) 1877-11-06 Improvement in washing-machines
DK1032705T3 (da) * 1997-10-30 2012-03-26 Cold Spring Harbor Lab Probearrays og fremgangsmåder til at benytte probearrays til at skelne mellem DNA

Also Published As

Publication number Publication date
EP2019872A2 (en) 2009-02-04
EP2019872B1 (en) 2011-10-26
ATE530670T1 (de) 2011-11-15
ES2375865T3 (es) 2012-03-07
US7985549B2 (en) 2011-07-26
WO2007135568A2 (en) 2007-11-29
CA2652087A1 (en) 2007-11-29
EP1857559A1 (en) 2007-11-21
WO2007135568A3 (en) 2008-02-28
US20090252740A1 (en) 2009-10-08

Similar Documents

Publication Publication Date Title
DK2019872T3 (da) Fremgangsmåde til forudsigelse af modtageligheden over for TNF-blokkere
DE602005009702D1 (de) Esr1 und gebärmutterhalskrebs
MX2019008675A (es) Variantes de hidroxiesteroide 17-beta deshidrogenasa 13 (hsd17b13) y usos de estas.
BRPI0715346A2 (pt) Detecção de analitos e ácidos nucléicos
DK3178559T3 (da) Integreret indretning til at udføre ekstraktion af nukleinsyre og diagnosetest på flere biologiske prøver
DK2132339T3 (da) Fremgangsmåde til detektering af en analyt i en biologisk matrix
ATE502122T1 (de) Chemisch modifizierte oligonukleotidprimer zur nukleinsäureamplifikation
WO2008115419A3 (en) Gene expression markers for prediction of patient response to chemotherapy
GEP20146107B (en) Method of identifying disease risk factors
DK2258871T3 (da) Fremgangsmåder og nukleinsyrer til analyse af celleproliferative lidelser
DK2083673T3 (da) System til fluiddistribution med elektrokemisk detektering af analytkoncentrationsniveauer
ATE534748T1 (de) Direkter snp-nachweis mit nichtamplifizierter dna
WO2011133949A3 (en) Genetic risk analysis in reward deficiency syndrome
EP2570500A3 (en) Genetic markers of mental illness
EP2372356A4 (en) SENSOR CHIP, BIODELECTOR SYSTEM, BIOLOGICAL SAMPLE TEMPERATURE MEASUREMENT METHOD, BLOOD SAMPLING TEMPERATURE MEASUREMENT METHOD, AND ANALYTE CONCENTRATION MEASUREMENT METHOD IN BLOOD SAMPLE
WO2007133682A3 (en) 100% sequence identity detection methods for variable genomes
DK2114990T3 (da) Fremgangsmåde til forudsigelse af NSCLC-patienters respons på behandling med en EGFR-TK-inhibitor
WO2008113111A8 (en) Assay for gene expression
WO2008088861A3 (en) Gene polymorphisms predictive for dual tki therapy
ATE493517T1 (de) Kontrollgene zur normalisierung von genexpressionsanalysedaten
DE602008006254D1 (de) Doppel-oligonukleotid-nukleinsäurenachweisverfahren
DE502006002073D1 (de) Verfahren zur verhinderung der zeitabhängigen rna-expression in biologischen zellen
WO2007001310A3 (en) Methods and compositions for detecting rhinoviruses
WO2009151757A3 (en) Method and apparatus for forensic screening
WO2009061640A3 (en) Hepatitis b virus (hbv) specific oligonucleotide sequences